Tag: drug

Posted on

Vectura Extends Novartis Deal For VR315 Lung Drug – Fox Business


Stockopedia

Vectura Extends Novartis Deal For VR315 Lung Drug
Fox Business
VX) for its generic asthma medicine VR315, covering markets outside Europe and North America. The deal follows hot on the heals of a US licensing agreement for the drug with an unnamed company earlier this week, and means Vectura has now licensed the …
VECTURA GROUP PLC : VR315 RoW License Agreement4-traders (press release)
Vectura signs up Sandoz for asthma drug in RoW; good results for ALK Abello …The Pharma Letter
Vectura agrees new licensing deal with Sandoz for asthma treatmentStockopedia

all 8 news articles »

View full post on asthma – Google News

Posted on

Roche Asthma Drug Meets Primary Endpoint In Phase II Study – Fox Business

Roche Asthma Drug Meets Primary Endpoint In Phase II Study
Fox Business
VX) Thursday said that a phase II study of its investigational asthma treatment lebrikizumab met its primary endpoint in a mid-stage trial. –Lebrikizumab isa humanized monoclonal antibody designed to block interleukin-13 (IL-13) cytokine. …
IL-13 Blocker Helps Asthma ControlMedPage Today
Experimental Drug Promising Against Tough-to-Treat AsthmaU.S. News & World Report
Roche asthma drug shows promise in mid-stage trialReuters
Bloomberg –4-traders (press release) –San Francisco Chronicle
all 10 news articles »

View full post on asthma – Google News

Posted on

Vectura Signs Up US Partner For VR315 Lung Drug – NASDAQ

Vectura Signs Up US Partner For VR315 Lung Drug
NASDAQ
LN) said Wednesday it has signed a US licensing deal for its generic asthma medicine VR315 with an unnamed "leading international pharmaceutical company." VR315, a drug that industry observers say is a copycat version of GlaxoSmithKline PLC's (GSK. …
Vectura signs US license agreement for VR315 productStock Market Wire
Vectura gets new US partner for copy of lung drugReuters
US deal for Vectura; takeover bid for AMAGThe Pharma Letter
Pharmaceutical Business Review
all 12 news articles »

View full post on asthma – Google News

Posted on

Drug Expenses for Children with Asthma More Than Doubled in 10 Years – HealthNewsDigest.com


HealthNewsDigest.com

Drug Expenses for Children with Asthma More Than Doubled in 10 Years
HealthNewsDigest.com
By Agency for Healthcare Research and Quality (HealthNewsDigest.com) – The percentage of American children treated for asthma increased while their annual drug expenses more than doubled over a 10-year period, according to the latest News and Numbers …

and more »

View full post on asthma – Google News

Posted on

NICE consults on asthma drug reducing procedure – InPharm

NICE consults on asthma drug reducing procedure
InPharm
NICE has launched a consultation in the UK on a new medical procedure which, if it proves safe and effective, may be a threat to established asthma drugs. Bronchial thermoplasty is the first non-drug asthma treatment the health watchdog has looked at, …
NICE issue draft guidance on surgery for severe asthmaHealthcare Today
NICE to consider first non-drug treatment for asthmaOnMedica

all 3 news articles »

View full post on asthma – Google News

Posted on

Study: In Asthma Patients, Placebo Treatments Feel Just as Good as the Drug – TIME


ABC News

Study: In Asthma Patients, Placebo Treatments Feel Just as Good as the Drug
TIME
A new Harvard Medical School investigation in asthma patients shows that the "placebo effect" — in which patients experience real benefits from sham treatments — can be as effective as standard medical therapy. The researchers recruited 39 patients …
The Placebo Effect, This Time in AsthmaWall Street Journal (blog)
Powerful Placebo Effect Revealed by Asthma StudyHealthNews
Asthma symptom changes reflect placebo effectCBC.ca
ThirdAge –MinnPost.com (blog) –Los Angeles Times
all 44 news articles »

View full post on asthma – Google News

Posted on

MediciNova, Zhejiang Announce Execution Of China JV To Develop Astma Drug – RTT News

MediciNova, Zhejiang Announce Execution Of China JV To Develop Astma Drug
RTT News
(RTTNews) – MediciNova Inc. (MNOV: News ) and Zhejiang Medicine Co., Ltd. Wednesday announced the execution of an agreement for the formation of a Joint Venture to develop and commercialize MediciNova's asthma drug MN-221 in China. …
Chinese Joint Venture CompletedMarketWatch (press release)

all 4 news articles »

View full post on asthma – Google News